AngioDynamics (ANGO) Reports Q1 Loss, Misses Revenue Estimates

AngioDynamics (ANGO) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of$ 0.15. This compares to loss of $0.12 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 26.67%. A quarter ago, it was expected that this medical device maker would post a loss of$ 0.20 per share when it actually produced a loss of $0.06, delivering a surprise of 70%.Over the last four quarters, the company has ...